This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suh, N. Articles by Reddy, B. S. Search for Related Content PubMed PubMed Citation Articles by Suh, N. Articles by Reddy, B. S. Related Collections Preclinical Intervention Preclinical Intervention: In Vivo (Animals): Drugs, Nutritional Interventions, Mechanisms

Pterostilbene, an Active Constituent of Blueberries, Suppresses Aberrant Crypt Foci Formation in the Azoxymethane-Induced Colon Carcinogenesis Model in Rats

Authors' Affiliations: ¹ Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey and ² U.S. Department of Agriculture, Agricultural Research Service, Natural Products Utilization Research Unit, University, Mississippi

Requests for reprints: Nanjoo Suh, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 164 Frelinghuysen Road, Piscataway, NJ 08854. Phone: 732-445-3400, ext. 226; Fax: 732-445-0687; E-mail: nsuh{at}rci.rutgers.edu or Agnes M. Rimando, United States Department of Agriculture, Agricultural Research Service, Natural Products Utilization Research Unit, PO Box 8048, University, MS 38677. Phone: 662-915-1037; Fax: 662-915-1035; E-mail: arimando{at}msa-oxford.ars.usda.gov.

Purpose: Epidemiologic studies have linked the consumption of fruits and vegetables to reduced risk of several types of cancer. Laboratory animal model studies have provided evidence that stilbenes, phenolic compounds present in grapes and blueberries, play a role in inhibiting the risk of certain cancers. Pterostilbene, a naturally occurring stilbene from blueberries, was tested for its preventive activity against colon carcinogenesis.

Experimental Design: Experiments were designed to study the inhibitory effect of pterostilbene against the formation of azoxymethane-induced colonic aberrant crypt foci (ACF) preneoplastic lesions in male F344 rats. Beginning at 7 weeks of age, rats were treated with azoxymethane (15 mg/kg body weight s.c., once weekly for 2 weeks). One day after the second azoxymethane treatment, rats were fed experimental diets containing 0 or 40 ppm of pterostilbene. At 8 weeks after the second azoxymethane treatment, all rats were sacrificed, and colons were evaluated for ACF formation and for inhibition of inducible nitric oxide synthase (iNOS) and proliferating cell nuclear antigen. Effects on mucin MUC2 were also determined.

Results: Administration of pterostilbene for 8 weeks significantly suppressed azoxymethane-induced formation of ACF (57% inhibition, P < 0.001) and multiple clusters of aberrant crypts (29% inhibition, P < 0.01). Importantly, dietary pterostilbene also suppressed azoxymethane-induced colonic cell proliferation and iNOS expression. Inhibition of iNOS expression by pterostilbene was confirmed in cultured human colon cancer cells.

Conclusions: The results of the present study suggest that pterostilbene, a compound present in blueberries, is of great interest for the prevention of colon cancer.

This article has been cited by other articles:

				M.-H. Pan, Y.-S. Chiou, W.-J. Chen, J.-M. Wang, V. Badmaev, and C.-T. Ho Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells Carcinogenesis, July 1, 2009; 30(7): 1234 - 1242. [Abstract] [Full Text] [PDF]

				X. Han, T. Zheng, Q. Lan, Y. Zhang, B. A. Kilfoy, Q. Qin, N. Rothman, S. H. Zahm, T. R. Holford, B. Leaderer, et al. Genetic Polymorphisms in Nitric Oxide Synthase Genes Modify the Relationship between Vegetable and Fruit Intake and Risk of Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1429 - 1438. [Abstract] [Full Text] [PDF]

				A. Bishayee Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials Cancer Prevention Research, May 1, 2009; 2(5): 409 - 418. [Abstract] [Full Text] [PDF]

				L. Schmidlin, A. Poutaraud, P. Claudel, P. Mestre, E. Prado, M. Santos-Rosa, S. Wiedemann-Merdinoglu, F. Karst, D. Merdinoglu, and P. Hugueney A Stress-Inducible Resveratrol O-Methyltransferase Involved in the Biosynthesis of Pterostilbene in Grapevine Plant Physiology, November 1, 2008; 148(3): 1630 - 1639. [Abstract] [Full Text] [PDF]

				Q. Ma, Y. Wang, X. Gao, Z. Ma, and Z. Song L-Arginine Reduces Cell Proliferation and Ornithine Decarboxylase Activity in Patients with Colorectal Adenoma and Adenocarcinoma Clin. Cancer Res., December 15, 2007; 13(24): 7407 - 7412. [Abstract] [Full Text] [PDF]